{"schema_version":"1","generated_at":"2026-10-29T13:04:46.918Z","data_as_of":null,"url":"https://www.findmykol.com/kol/cecilia-fu","json_url":"https://www.findmykol.com/kol/cecilia-fu/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"cecilia-fu","name":"Cecilia Fu","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Children's Hospital of Los Angeles","institution_url":"https://www.findmykol.com/institution/children-s-hospital-of-los-angeles","city":"Los Angeles","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1982793907","openalex":"A5027962644"},"summary":"Cecilia Fu is an Oncology physician affiliated with Children's Hospital of Los Angeles. OpenAlex indexes 58 publications with 1,317 citations (h-index 18).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":58,"cited_by_count":1317,"h_index":18,"latest_activity_year":2024,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Alexion Pharmaceuticals, Inc.","program_year":2024,"amount_usd":27.26,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1982793907"},{"payer":"Amgen Inc.","program_year":2022,"amount_usd":30.19,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1982793907"},{"payer":"Alexion Pharmaceuticals, Inc.","program_year":2021,"amount_usd":21.68,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1982793907"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1982793907","source":"payments"},"prescribing":{"data_year":2019,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cardiovascular","share_pct":59.3,"classes_total":1,"classes":[{"class":"ACE inhibitor","setting":"prescribed","share_pct":59.3,"drugs":[{"name":"Lisinopril","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":40.7,"classes_total":1,"classes":[{"class":"Biguanide (metformin)","setting":"prescribed","share_pct":40.7,"drugs":[{"name":"Metformin Hcl","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Clinical trial recruitment of people who speak languages other than English: a Children’s Oncology Group report","year":2024,"journal":"JNCI Cancer Spectrum","source_url":"https://doi.org/10.1093/jncics/pkae047","status":"verified"},{"title":"Clinical trial recruitment of people who speak languages other than English: a Children’s Oncology Group report","year":2024,"journal":"UNC Libraries","source_url":"https://doi.org/10.17615/z3q8-sw20","status":"verified"},{"title":"Supplementary Table S2 from A Heritable Missense Polymorphism in <i>CDKN2A</i> Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution","year":2023,"source_url":"https://doi.org/10.1158/0008-5472.22410776.v1","status":"verified"},{"title":"Supplementary Table S2 from A Heritable Missense Polymorphism in <i>CDKN2A</i> Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution","year":2023,"source_url":"https://doi.org/10.1158/0008-5472.22410776","status":"verified"},{"title":"Supplementary Table S1 from A Heritable Missense Polymorphism in <i>CDKN2A</i> Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution","year":2023,"source_url":"https://doi.org/10.1158/0008-5472.22410779.v1","status":"verified"}],"source":"works"},"contact":{"address_1":"4650 W SUNSET BLVD","address_2":"MS# 54","city":"Los Angeles","state":"CA","zip":"900276062","phone":"323-361-2121","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1982793907","source":"identity"},"similar":[{"name":"Kevin Lemley","slug":"kevin-lemley","institution":"Children's Hospital of Los Angeles","specialty":"Pediatric Nephrology","url":"https://www.findmykol.com/kol/kevin-lemley","json_url":"https://www.findmykol.com/kol/kevin-lemley/profile.json"},{"name":"Floyd Gilles","slug":"floyd-gilles","institution":"Children's Hospital of Los Angeles","specialty":"Neurology with Special Qualifications in Child Neurology","url":"https://www.findmykol.com/kol/floyd-gilles","json_url":"https://www.findmykol.com/kol/floyd-gilles/profile.json"},{"name":"Ryan Handoko","slug":"ryan-handoko","institution":"Children's Hospital of Los Angeles","specialty":"Pediatric Cardiology","url":"https://www.findmykol.com/kol/ryan-handoko","json_url":"https://www.findmykol.com/kol/ryan-handoko/profile.json"},{"name":"Robert Venick","slug":"robert-venick","institution":"Children's Hospital of Los Angeles","specialty":"Pediatric Gastroenterology","url":"https://www.findmykol.com/kol/robert-venick","json_url":"https://www.findmykol.com/kol/robert-venick/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2011-08-01","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2019}},"methodology_url":"https://www.findmykol.com/about#methodology"}